HIGHLIGHTS
- who: Zhenhua Luo from the Johannes Gutenberg University Mainz, Germany have published the Article: The relationship between soluble lymphocyte activation gene-3 and coronary artery disease, in the Journal: (JOURNAL)
- what: The authors investigated the levels of sLAG3 in patients with CAD, and its potential clinical association with the disease. The study demonstrates that sLAG3 level is reduced in patients with CAD, accompanied by downregulation of LAG3 gene in peripheral blood.
- how: This study was carried out in accordance with the Declaration of Helsinki.
- future: The definitive role of sLAG3 in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.